BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

737 related articles for article (PubMed ID: 14758941)

  • 1. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis.
    Scott RM; Smith JL; Robertson RL; Madsen JR; Soriano SG; Rockoff MA
    J Neurosurg; 2004 Feb; 100(2 Suppl Pediatrics):142-9. PubMed ID: 14758941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Moyamoya disease in the adult population with pial synangiosis.
    Lin N; Aronson JP; Manjila S; Smith ER; Scott RM
    J Neurosurg; 2014 Mar; 120(3):612-7. PubMed ID: 24405066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative contributions of the middle meningeal artery and superficial temporal artery in revascularization surgery for moyamoya syndrome in children: the results of superselective angiography.
    King JA; Armstrong D; Vachhrajani S; Dirks PB
    J Neurosurg Pediatr; 2010 Feb; 5(2):184-9. PubMed ID: 20121368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome.
    Smith ER; McClain CD; Heeney M; Scott RM
    Neurosurg Focus; 2009 Apr; 26(4):E10. PubMed ID: 19335126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moyamoya syndrome associated with Down syndrome: outcome after surgical revascularization.
    Jea A; Smith ER; Robertson R; Scott RM
    Pediatrics; 2005 Nov; 116(5):e694-701. PubMed ID: 16263984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pial synangiosis in patients with moyamoya younger than 2 years of age.
    Jackson EM; Lin N; Manjila S; Scott RM; Smith ER
    J Neurosurg Pediatr; 2014 Apr; 13(4):420-5. PubMed ID: 24527861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down syndrome and moyamoya: clinical presentation and surgical management.
    See AP; Ropper AE; Underberg DL; Robertson RL; Scott RM; Smith ER
    J Neurosurg Pediatr; 2015 Jul; 16(1):58-63. PubMed ID: 25837890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pial synangiosis for moyamoya disease. The Bordeaux experience].
    Jecko V; Penchet G; Champeaux C
    Neurochirurgie; 2016 Aug; 62(4):190-6. PubMed ID: 27113323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical Revascularization for Children with Moyamoya Disease: A New Modification to the Pial Synangiosis.
    Chen C; Wang H; Hou B; Luo L; Guo Y
    World Neurosurg; 2018 Feb; 110():e203-e211. PubMed ID: 29102749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis.
    Hankinson TC; Bohman LE; Heyer G; Licursi M; Ghatan S; Feldstein NA; Anderson RC
    J Neurosurg Pediatr; 2008 Mar; 1(3):211-6. PubMed ID: 18352765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pial synangiosis for moyamoya syndrome in children with sickle cell anemia: a comprehensive review of reported cases.
    Kennedy BC; McDowell MM; Yang PH; Wilson CM; Li S; Hankinson TC; Feldstein NA; Anderson RC
    Neurosurg Focus; 2014 Jan; 36(1):E12. PubMed ID: 24380478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moyamoya syndrome associated with neurofibromatosis Type 1: perioperative and long-term outcome after surgical revascularization.
    Koss M; Scott RM; Irons MB; Smith ER; Ullrich NJ
    J Neurosurg Pediatr; 2013 Apr; 11(4):417-25. PubMed ID: 23373626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moyamoya syndrome and PHACE syndrome: clinical and radiographic characterization of the intracranial arteriopathy and response to surgical revascularization.
    Jernigan S; Storey A; Hammer C; Riordan C; Orbach DB; Scott RM; Smith E
    J Neurosurg Pediatr; 2019 Feb; 23(4):493-497. PubMed ID: 30717056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of repeat revascularization surgery for moyamoya disease after an unsuccessful indirect revascularization. Clinical article.
    Pandey P; Steinberg GK
    J Neurosurg; 2011 Aug; 115(2):328-36. PubMed ID: 21529138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of disease in unilateral moyamoya syndrome.
    Smith ER; Scott RM
    Neurosurg Focus; 2008; 24(2):E17. PubMed ID: 18275294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late (5-20 years) outcomes after STA-MCA anastomosis and encephalo-duro-myo-arterio-pericranial synangiosis in patients with moyamoya disease.
    Kuroda S; Nakayama N; Yamamoto S; Kashiwazaki D; Uchino H; Saito H; Hori E; Akioka N; Kuwayama N; Houkin K
    J Neurosurg; 2020 Mar; 134(3):909-916. PubMed ID: 32168480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pial synangiosis for moyamoya syndrome in children.
    Adelson PD; Scott RM
    Pediatr Neurosurg; 1995; 23(1):26-33. PubMed ID: 7495663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical Treatment for Patients with Moyamoya Syndrome and Type 1 Neurofibromatosis.
    Porras JL; Yang W; Garzon-Muvdi T; Xu R; Blakeley J; Belzberg A; Caplan JM; Khalid S; Colby GP; Coon AL; Tamargo RJ; Ahn ES; Huang J
    World Neurosurg; 2017 Mar; 99():19-25. PubMed ID: 27876659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chorea in the clinical presentation of moyamoya disease: results of surgical revascularization and a proposed clinicopathological correlation.
    Ahn ES; Scott RM; Robertson RL; Smith ER
    J Neurosurg Pediatr; 2013 Mar; 11(3):313-9. PubMed ID: 23289915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative neurological deterioration in pediatric moyamoya disease: watershed shift and hyperperfusion.
    Hayashi T; Shirane R; Fujimura M; Tominaga T
    J Neurosurg Pediatr; 2010 Jul; 6(1):73-81. PubMed ID: 20593991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.